Revamped APS Criteria and Their Impact on Clinical Research Revamped APS Criteria and Their Impact on Clinical Research
Dr Medha Barbhaiya and Dr Doruk Erkan answer questions about the new ACR-EULAR criteria and how they improve upon Sapporo APS classification criteria last updated in 2006.Hospital for Special Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2023 Category: Consumer Health News Tags: Rheumatology Expert Interview Source Type: news
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 6, 2023 Category: Dermatology Source Type: news
Key Data on Psoriatic Arthritis From ACR 2023 Key Data on Psoriatic Arthritis From ACR 2023
Key data on psoriatic arthritis from ACR 2023 include treatment studies examining izokibep, apremilast, and TAK-279, as well as analysis of treatment response and difficult-to-treat cases.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2023 Category: Consumer Health News Tags: Rheumatology ReCAP Source Type: news
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 5, 2023 Category: Dermatology Source Type: news
PsA Raises Mortality Risk, but Unevenly
(MedPage Today) -- Swedes with psoriatic arthritis (PsA) tended to die earlier than other people, a national case-control study indicated, but the risk varied considerably among different subgroups.
Overall all-cause mortality was 11% higher for... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 4, 2023 Category: Dermatology Source Type: news
Four JAK Inhibitors Have Comparable Efficacy, Safety for RA
FRIDAY, Dec. 1, 2023 -- For patients with rheumatoid arthritis, the efficacy and safety of four Janus kinase (JAK) inhibitors is comparable, according to a study published online Nov. 1 in Rheumatology.
Shinya Hayashi, M.D., from the Kobe... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2023 Category: Pharmaceuticals Source Type: news
Ins and Outs of Rheumatoid Arthritis
In the webinar, Stanley B. Cohen, MD, broke down all things RA including what boosts your chances of having it, what risks come with RA, and more. (Source: WebMD Health)
Source: WebMD Health - December 1, 2023 Category: Consumer Health News Source Type: news
Asheville Arthritis & amp; Osteoporosis Center Partners with House Rx to Enhance Patient Care Through Medically Integrated Dispensing
Asheville Arthritis & Osteoporosis Center, a community rheumatology clinic based in North Carolina, will be adopting a new care model aimed at improving patient access to life-improving specialty medications. Asheville Arthritis & Osteoporosis Center will provide patients with faster and... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 1, 2023 Category: Pharmaceuticals Tags: LIC Source Type: news
New Data on Bimekizumab in Psoriatic Arthritis
(MedPage Today) -- At the American College of Rheumatology annual meeting, new data was presented on the long-term safety and efficacy of bimekizumab (Bimzelx), a dual interleukin (IL)-17A/F inhibitor, in active psoriatic arthritis.
In this second... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 30, 2023 Category: Dermatology Source Type: news
Rheumatology Fills Over 97% of Fellowship Programs for 2024 Rheumatology Fills Over 97% of Fellowship Programs for 2024
Adult rheumatology remains popular but pediatric rheumatology continues to be less successful, filling only 55% of programs.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
COVID Vax T-Cell Responses Help B-Cell –Deficient Patients COVID Vax T-Cell Responses Help B-Cell –Deficient Patients
The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 29, 2023 Category: Internal Medicine Tags: Rheumatology Source Type: news
Rheumatology Patients Prefer Office Visits to Telemedicine Rheumatology Patients Prefer Office Visits to Telemedicine
Despite relatively high approval rates overall, patient satisfaction was lower among those treated via telemedicine at two tertiary medical centers.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - November 29, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
DMARDs Linked to Reduced Thyroid Disease Incidence DMARDs Linked to Reduced Thyroid Disease Incidence
In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 29, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Conditional Recommendations Rule in New SARD ILD Guidelines Conditional Recommendations Rule in New SARD ILD Guidelines
In spring 2024, the ACR is expected to release guidelines to help inform the screening, monitoring, and treatment of interstitial lung disease (ILD) in people with SARDs.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Telitacicept Shows Efficacy, Safety in MTX-Resistant RA Telitacicept Shows Efficacy, Safety in MTX-Resistant RA
Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology Source Type: news
